Display Settings:

Format

Send to:

Choose Destination
    Antimicrob Agents Chemother. 1999 Mar;43(3):717-21.

    Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods.

    Source

    Department of Pharmacy Services, Detroit Receiving Hospital, Michigan 48201, USA.

    Abstract

    This in vitro study evaluated the activities of vancomycin, LY333328, and teicoplanin alone and in combination with gentamicin, rifampin, and RP59500 against Staphylococcus aureus isolates with intermediate susceptibilities to vancomycin. Ampicillin-sulbactam and trovafloxacin were also evaluated. LY333328 and ampicillin-sulbactam resulted in bactericidal activity against all isolates. The combination of gentamicin with glycopeptides showed synergistic activity, while rifampin had no added benefit.

    PMID:
    10049300
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC89193
    Free PMC Article

    Images from this publication.See all images (3) Free text

    FIG. 1
    FIG. 3
    FIG. 2

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk